Initial and Subsequent Healthcare-Associated Infections in Intensive Care Patients
NCT07916649, Active not recruiting, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Initial and Subsequent Healthcare-Associated Infections in Intensive Care Patients | ClinicalTrials.gov |
| NCT number | NCT07916649 | ClinicalTrials.gov |
| Status | Active not recruiting | ClinicalTrials.gov |
| Enrollment | 243 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | ClinicalTrials.gov |
| Conditions | Cross Infection, Intensive Care Units, Microbial Disease | ClinicalTrials.gov |
| First posted | 2026-11-04 | ClinicalTrials.gov |
| Last updated | 2026-11-04 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change in Infection Site Between Index and First Subsequent Healthcare-Associated Infections | At diagnosis of the index healthcare-associated infection (baseline) and at diagnosis of the first subsequent healthcare-associated infection during the same ICU stay, assessed up to 120 days after baseline. | Among patients who develop a subsequent healthcare-associated infection (HAI), infection sites will be compared between the index infection and the first subsequent infection using paired patient-level data. Changes in infection sites will be assessed using the number and percentage of patients with different infection sites between episodes. Infection-site distributions and transitions will be presented using frequency tables and transition matrices. | ClinicalTrials.gov |
| Primary | Change in Causative Microorganisms Between Index and First Subsequent Healthcare-Associated Infections | At diagnosis of the index healthcare-associated infection (baseline) and at diagnosis of the first subsequent healthcare-associated infection during the same ICU stay, assessed up to 120 days after baseline. | Among patients who develop a subsequent healthcare-associated infection (HAI), causative microorganisms identified during the index infection and the first subsequent infection will be compared using paired patient-level data. Changes in causative microorganisms will be evaluated based on microbiological records. The number and percentage of patients with changes in causative microorganisms will be reported, and microorganism transitions will be summarized using frequency distributions and transition tables. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)